Greater Southern California Node of the Clinical Trials Network

临床试验网络大南加州节点

• 批准号: 10336684
• 负责人: YIH-ING HSER
• 金额: $ 11.71万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-06-01 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10336684
• 关键词: Address; Area; Behavior Therapy; California; Cellular Phone; Clinical Research; Clinical Treatment; Clinical Trials Network; Collaborations; Concept Review; Data Science; Development; Drug abuse; Electronic Health Record; Faculty; Generations; Goals; Health; Health Care Research; Health Services Accessibility; Health care facility; Healthcare; Helping to End Addiction Long-term; Improve Access; Individual; Interdisciplinary Study; Intervention; Intervention Studies; Journals; Lead; Leadership; Mission; Modeling; Morbidity - disease rate; Multi-Institutional Clinical Trial; National Institute of Drug Abuse; New York; Pharmaceutical Preparations; Pharmacology; Pharmacotherapy; Population; Population Heterogeneity; Principal Investigator; Protocols documentation; Public Health; Research; Research Infrastructure; Research Personnel; Research Priority; Research Support; Seminal; Substance Use Disorder; System; Talents; Technology; Telemedicine; Testing; Training; Treatment Effectiveness; Treatment outcome; United States; United States National Institutes of Health; Vulnerable Populations; Work; base; clinical practice; clinical trial implementation; comorbidity; design; eHealth; health care service organization; health care settings; implementation science; implementation strategy; improved; improved outcome; innovation; innovative technologies; mHealth; meetings; mortality; opioid epidemic; opioid use disorder; overdose death; protocol development; response; rural area; rural setting; service delivery; student training; substance use treatment; treatment services; uptake

Project Summary/Abstract This application, responding to the Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NOT-DA-20-047), requests an administrative supplement to the Rural Expansion of Medication Treatment for Opioid Use Disorder (Rural MOUD, CTN-0102). The main purpose of the parent project is to investigate the impact of telemedicine (TM) on MOUD access and retention for individuals with OUD in rural primary care settings. The coronavirus disease 2019 (COVID-19, or COVID for short) pandemic has forced many health care systems to rapidly implement remote care models, which is of direct relevance to this project. Building upon the existing research plan, we request an administrative supplement to conduct a thorough investigation of COVID’s impact on TM practices and access to MOUD in rural communities. In addition to characterizing changes in attitudes and perceptions regarding TM for OUD treatment, we will investigate and assess the impact of COVID over the next 2 years with regard to changes in MOUD access and services (especially TM) in rural primary care settings and in OUD patients’ use of substances (particularly opioids) and health conditions. Study specific aims include: Aim 1. To assess changes in MOUD access and services (especially TM) in rural primary care settings over the COVID pandemic, and Aim 2. To assess changes in OUD patients’ substance use (particularly opioids) and health conditions over the COVID pandemic. The supplement funding will support (1) qualitative data collection and analysis that includes focus groups and semi-structured interviews to document COVID impact from the perspective of community stakeholders, providers, and patients drawn from primary care clinics serving rural communities, and (2) quantitative data collection and analysis that includes health records for patients served by the rural primary care clinics as well as self-report from OUD patients’ participant surveys to investigate COVID impact on the use of healthcare, TM, and substances. Findings will contribute to scientific knowledge regarding COVID impact, responses, and consequences in rural communities, as well as to inform and shape future development of remote care models.

项目摘要/摘要 此申请，响应有关可用性的特殊利益通知（NOSI） 关于2019年小说的研究的行政补品和紧急竞争修订 冠状病毒（NOT-DA-20-047）要求为农村扩张的行政补充 阿片类药物使用障碍的药物治疗（农村MOUD，CTN-0102）。主要目的 家长项目是为了调查远程医疗（TM）对MOUD访问和保留的影响 在粗糙的初级保健环境中患有OUD的人。 2019年冠状病毒病（COVID-19，或 简短的COVID大流行迫使许多医疗保健系统迅速实施远程护理 模型，这与该项目直接相关。在现有研究计划的基础上，我们 要求进行行政补充，以对Covid对TM的影响进行彻底调查 在农村社区中的实践和途径。除了表征变化 对OUD治疗的TM的态度和看法，我们将调查和评估影响 在接下来的两年中，Covid关于MOUD访问和服务的变化（尤其是TM） 在粗糙的初级保健环境中，在OUD患者中使用物质（部分为阿片类药物）和健康 状况。研究具体目的包括：目标1。评估MOUD访问和服务的变化 （尤其是TM）在COVID大流行的粗糙初级保健环境中，目标2。 OUD患者使用物质的变化（部分为阿片类药物）和COVID的健康状况 大流行。补充资金将支持（1）定性数据收集和分析， 包括焦点小组和半结构化访谈，以记录来自 社区利益相关者，提供者和患者从初级保健诊所汲取的观点 为农村社区提供服务，以及（2）包括健康在内的定量数据收集和分析 由Rough初级保健诊所服务的患者以及OUD患者的自我报告的记录 参与者调查以调查共证对医疗保健，TM和物质使用的影响。 调查结果将有助于科学知识，以了解相互作用的影响，反应和 农村社区的后果，以及为遥远的未来发展提供信息 护理模型。